The DFG funds clinical trials within the framework of regular funding programmes. Funding is granted for prospective, interventional and confirmatory trials on new procedures. This encompasses therapeutic trials, including pharmacological trials (“therapeutic confirmatory”), as well as prognostic and diagnostic trials in phases II - IV, the aim of which is to test the efficacy of a new procedure. Trials must be carried out at multiple centres. They must be of high scientific quality and originality and clinically relevant. Applicants should have experience in relevant trial-related studies and the projects must comply with the Guidelines on Good Clinical Practice (ICH-GCP).
Draft proposals can be submitted at any time. Applicants whose draft proposals are evaluated positively will be asked to submit full proposals.